Literature DB >> 3679692

Biosynthesis of taurine peptides in brain cytoplasmic fraction in vitro.

P Lähdesmäki1.   

Abstract

Brain homogenates and their cell-free soluble fraction incorporated labelled [14C]taurine, [14C]glutamic acid, [14C]aspartic acid and [14C]serine into a number of low-molecular weight peptides, among which glutamyl-, aspartyl- and seryl-taurines and their N-acetylated derivatives were identified. A partially purified cytoplasmic fraction catalyzed the formation of glutamyl-taurine. Excesses of aspartic acid and serine inhibited this reaction. Biosynthetic products were analyzed on thin-layer chromatography plates by an autoradiographic X-film technique and identified with the aid of synthetic peptides or endogenous synaptosomal peptides, whose structure was determined with mass spectrometry. gamma-Glutamyl-taurine was also formed through a group translocation mechanism from glutathione and taurine by the enzymes of the gamma-glutamyl cycle. The catalytic activity of the membraneous enzyme was identical with that of the commercial gamma-glutamyltransferase.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3679692     DOI: 10.3109/00207458708991804

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  3 in total

1.  Displacement of excitatory amino acid receptor ligands by acidic oligopeptides.

Authors:  V Varga; R Janáky; K M Marnela; J Gulyás; P Kontro; S S Oja
Journal:  Neurochem Res       Date:  1989-12       Impact factor: 3.996

2.  Interactions of gamma-L-glutamyltaurine with excitatory aminoacidergic neurotransmission.

Authors:  V Varga; R Janáky; K M Marnela; P Saransaari; S S Oja
Journal:  Neurochem Res       Date:  1994-03       Impact factor: 3.996

3.  Effects of Novel Calpain Inhibitors in Transgenic Animal Model of Parkinson's disease/dementia with Lewy bodies.

Authors:  Getaw Worku Hassen; Leo Kesner; Alfred Stracher; Abraham Shulman; Edward Rockenstein; Michael Mante; Anthony Adame; Cassia Overk; Robert A Rissman; Eliezer Masliah
Journal:  Sci Rep       Date:  2018-12-27       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.